trending Market Intelligence /marketintelligence/en/news-insights/trending/Uk7yRr9J-gCMijxXu0AwNw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Ladenburg Thalmann downgrades Fidus Investment to 'neutral' from 'buy'

Street Talk Episode 56 - Latest bank MOE shows even the strong need scale to thrive

South State CenterState MOE Shows Even The Strong Need Scale To Thrive

Talking Bank Stocks, Playing The M&A Trade With Longtime Investor

Report: Kashkari Says Fed In Holding Pattern But Rate Cut Still Possible


Ladenburg Thalmann downgrades Fidus Investment to 'neutral' from 'buy'

Ladenburg Thalmann analyst Mickey Schleien downgraded Fidus Investment Corp. to "neutral" from "buy" and removed its price target.

The business development company reported adjusted second-quarter net investment income per share of 34 cents, which missed the consensus estimate of 38 cents and the analyst's estimate of 37 cents. Oaktree Medical's placement on full non-accrual resulted in an 11% quarter-over-quarter decrease in investment income, according to Schleien.

Oaktree Medical is under probe for allegedly improperly billing Medicare and making excessive opioid prescriptions, according to the report.

Merits include relatively low balance sheet leverage, dividend coverage and acceptable net investment income yield, Schleien said. The analyst also pointed out concerns such as investment concentration, credit watch investment levels and payment-in-kind income, and the lack of an incentive fee cap mechanism.